Relevant additions and changes to the 1 April 2014 issue of the Schedule of Pharmaceutical Benefits have been added to MAESTrO Australia

[:content [\1 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \space \T \h \e \space \f \o \l \l \o \w \i \n \g \space \a \d \d \i \t \i \o \n \s \space \a \n \d \space \c \h \a \n \g \e \s \space \h \a \v \e \space \b \e \e \n \space \a \d \d \e \d \space \t \o \space \M \A \E \S \T \r \O \space \A \u \s \t \r \a \l \i \a \: " ..."]]
Read more →

Several new features are currently in development and will be added soon

[:content [\T \h \e \s \e \space \f \e \a \t \u \r \e \s \space \i \n \c \l \u \d \e \space \l \i \n \k \s \space \t \o \space \D \U \S \C \space \O \u \t \c \o \m \e \space \S \t \a \t \e \m \e \n \t \s \space \( \2 \0 \1 \2 \- \2 \0 \1 \3 \) \space \a \n \d \space \i \m \p \r \o \v \e \d \space \s \u \m \m \a \r \i \e \s \space \f \o \r \space \P \B \A \C \space \m \e \e \t \i \n \g \s \space \a \n \d \space \a \p \p \l \i \c \a \n \t \s \. \space \T \h \e \space \s \u \m \m \a \r \i \e \s \space \w \i \l \l " ..."]]
Read more →

Enzalutamide to be reimbursed via PBS for the management of castration-resistant metastatic prostate cancer for men whose disease has progressed on or after docetaxel therapy

Astellas Pharma Australia has announced that Xtandi (enzalutamide) will be listed on the Pharmaceutical Benefits Scheme from 1st December 2014 for the ...

Read more →

Access to Medicines Working Group (AMWG) Communique - 28 October 2014

The communique from the 28 October 2014 AMWG meeting is now available on the PBS website. ...

Read more →

Hasty cuts may make it harder to access the new medicines that patients need

Health Minister, Sussan Ley’s announcement to list new medicines and vaccines on the PBS for cancer, blindness and shingles will ...

Read more →

Report on the collection of under co-payment data 2013-14

The 2013-14 Report on the Collection of PBS/RPBS Under Co-payment Prescription Data is now available from the PBS website. ...

Read more →

Commission of Audit report flawed on PBS

[:content [\1 \space \M \a \y \space \2 \0 \1 \4 \space \- \  \T \h \e \space \N \a \t \i \o \n \a \l \space \C \o \m \m \i \s \s \i \o \n \space \o \f \space \A \u \d \i \t \space \r \e \p \o \r \t \space \r \e \l \e \a \s \e \d \space \t \o \d \a \y \space \i \s \space \a \space \f \u \n \d \a \m \e \n \t \a \l \l \y \space \f \l \a \w \e \d \space \a \n \a \l \y \s \i \s \space \o \f \space \t \h \e \space \P \h \a \r \m \a \c \e \u \t \i \c \a \l \space \B \e \n \e \f \i \t \s " ..."]]
Read more →

Public Summary Documents from the November 2013 PBAC meeting - Risk Share Agreements

[:content [\1 \5 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \space \A \n \a \l \y \s \i \s \space \o \f \space \t \h \e \space \P \u \b \l \i \c \space \S \u \m \m \a \r \y \space \D \o \c \u \m \e \n \t \s \space \f \r \o \m \space \t \h \e \space \N \o \v \e \m \b \e \r \space \2 \0 \1 \3 \space \P \B \A \C \space \m \e \e \t \i \n \g \space \h \a \s \space \r \e \v \e \a \l \e \d \space \t \h \e \space \C \o \m \m \i \t \t \e \e " ..."]]
Read more →

European Medicines Agency and EUnetHTA review progress of their cooperation

[:content [\T \h \e \space \E \u \r \o \p \e \a \n \space \M \e \d \i \c \i \n \e \s \space \A \g \e \n \c \y \space \( \E \M \A \) \space \a \n \d \space \E \U \n \e \t \H \T \A \, \space \t \h \e \space \E \u \r \o \p \e \a \n \space \N \e \t \w \o \r \k \space \f \o \r \space \H \e \a \l \t \h \space \T \e \c \h \n \o \l \o \g \y \space \A \s \s \e \s \s \m \e \n \t \, \space \m \e \t \space \t \o \space \r \e \v \i \e \w \space \t \h \e \space \p \r \o \g \r \e \s \s \space \o \f " ..."]]
Read more →

Tax avoidance inquiry calls on nine 'big pharma' bosses to explain tax contribution

The bosses of nine of Australia's largest multinational pharmaceutical companies will appear in front of a Senate committee investigating corporate tax avoidance. ...

Read more →

97 per cent of Aussies want new cancer medicines subsidised through PBS

New findings released by Newspoll shows overwhelming support for access to new cancer medicines through the Pharmaceutical Benefits Scheme (PBS), for ...

Read more →

Cystic fibrosis drug approved for PBS listing, heralding 'better quality of life' for sufferers

Cystic fibrosis (CF) patients and their families are celebrating after the Federal Government listed a drug on the Pharmaceutical Benefits ...

Read more →

Call for submissions: Stage 3 of the PBAC post-market review of products used in the management of patients with diabetes mellitus

[:content [\T \h \e \space \c \a \l \l \space \f \o \r \space \p \u \b \l \i \c \space \s \u \b \m \i \s \s \i \o \n \s \space \i \s \space \n \o \w \space \o \p \e \n \space \f \o \r \space \S \t \a \g \e \space \3 \space \o \f \space \t \h \e \space \D \i \a \b \e \t \e \s \space \R \e \v \i \e \w \space \f \o \r \space \a \space \p \e \r \i \o \d \space \o \f \space \s \i \x " ..."]]
Read more →

New treatment for cancer approved for PBS listing

Pancreatic cancer drug Abraxane will be listed on the PBS from November 1.

The Australian Government has committed over $92 million ...

Read more →

Schedule of Pharmaceutical Benefits - 1 November 2014 update

The 1 November 2014 issue of the Schedule of Pharmaceutical Benefits is now available and in effect. The new issue contains ...

Read more →